Free Trial

BI Asset Management Fondsmaeglerselskab A S Buys 807 Shares of Waters Co. (NYSE:WAT)

Waters logo with Medical background

BI Asset Management Fondsmaeglerselskab A S raised its stake in Waters Co. (NYSE:WAT - Free Report) by 38.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,926 shares of the medical instruments supplier's stock after acquiring an additional 807 shares during the period. BI Asset Management Fondsmaeglerselskab A S's holdings in Waters were worth $1,085,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of WAT. Aster Capital Management DIFC Ltd purchased a new position in Waters in the fourth quarter worth about $28,000. Bank of Jackson Hole Trust bought a new position in Waters in the 4th quarter valued at approximately $34,000. Fortitude Family Office LLC increased its holdings in shares of Waters by 235.7% in the 4th quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier's stock worth $35,000 after purchasing an additional 66 shares in the last quarter. Steward Partners Investment Advisory LLC lifted its holdings in shares of Waters by 129.3% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier's stock valued at $35,000 after purchasing an additional 53 shares in the last quarter. Finally, Murphy & Mullick Capital Management Corp purchased a new stake in shares of Waters during the fourth quarter valued at $42,000. Hedge funds and other institutional investors own 94.01% of the company's stock.

Waters Stock Performance

WAT opened at $331.27 on Wednesday. The stock has a market capitalization of $19.71 billion, a price-to-earnings ratio of 30.93, a PEG ratio of 3.79 and a beta of 1.04. Waters Co. has a fifty-two week low of $279.24 and a fifty-two week high of $423.56. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.65 and a current ratio of 0.94. The company has a fifty day moving average of $358.01 and a 200 day moving average of $370.81.

Waters (NYSE:WAT - Get Free Report) last posted its earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 EPS for the quarter, topping analysts' consensus estimates of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. As a group, sell-side analysts forecast that Waters Co. will post 12.86 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the stock. Sanford C. Bernstein set a $400.00 target price on shares of Waters and gave the company an "outperform" rating in a research note on Wednesday, April 16th. UBS Group boosted their target price on shares of Waters from $405.00 to $410.00 and gave the company a "neutral" rating in a research note on Thursday, February 13th. Baird R W upgraded Waters from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, March 26th. KeyCorp raised Waters from a "sector weight" rating to an "overweight" rating and set a $460.00 target price on the stock in a report on Monday, March 31st. Finally, JPMorgan Chase & Co. boosted their price target on Waters from $380.00 to $390.00 and gave the company a "neutral" rating in a research note on Thursday, March 6th. Ten equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $392.13.

Check Out Our Latest Stock Report on Waters

Waters Profile

(Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Read More

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT - Free Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Waters Right Now?

Before you consider Waters, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.

While Waters currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines